ReviewCells, tissues, organs2008
Stem cell differentiation: cardiac repair.
Review in Cells, tissues, organs, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 25 citations in OpenAlex.
- Special issue on recent progress with hPSC-derived cardiovascular cells for organoids, engineered myocardium, drug discovery, disease models, and therapy.Pflugers Archiv : European journal of physiology · 2021Article
- Cell shape and cardiosphere differentiation: a revelation by proteomic profiling.Biochemistry research international · 2013Review
- Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition.Cytotherapy · 2012Article
- Personalized cardiac regeneration by stem cells-Hype or hope?The EPMA journal · 2011Article
- Embryonic stem cell-derived cardiomyocyte heterogeneity and the isolation of immature and committed cells for cardiac remodeling and regeneration.Stem cells international · 2011Article
- Translational lessons from scarless healing of cutaneous wounds and regenerative repair of the myocardium.Journal of molecular and cellular cardiology · 2010Review
- Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction.Stem cells and cloning : advances and applications · 2009Review
- Functional and histopathological improvement of the post-infarcted rat heart upon myoblast cell grafting and relaxin therapy.Journal of cellular and molecular medicine · 2009Article
- Over expression of Plk1 does not induce cell division in rat cardiac myocytes in vitro.PloS one · 2009Article
- Enhanced mobilization of CD34(+) progenitor cells expressing cell adhesion molecules in patients with STEMI.Clinical research in cardiology : official journal of the German Cardiac Society · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Cellular transplantation has been employed for several years to deliver donor cardiomyocytes to normal and injured hearts. Recent reports of a variety of stem cells with apparent cardiomyogenic potential have raised the possibility of cell transplantation-based therapeutic interventions for heart disease. Here we review the preclinical studies demonstrating that intracardiac transplantation of skeletal myoblasts, cardiomyocytes and cardiomyogenic stem cells is feasible. In addition, recent clinical studies of skeletal myoblast and adult stem cell transplantation for heart disease are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.